Parkinson's Disease Methods and Protocols - Mouradian, M. Maral; SpringerLink (Online service) (Totowa, NJ : Humana Press : Imprint: Humana, 2001)
Genetics -- Point Mutations in the ?-Synuclein Gene -- Autosomal Recessive Juvenile Parkinsonism (AR-JP): Genetic Diagnosis -- Molecular Pathogenetic Studies -- Parkinson's Disease, Dementia with Lewy Bodies, and Multiple System Atrophy as ?-Synucleinopathies -- ?-Synuclein/Amyloid Interactions -- Functional Defect Conferred by the Parkinson's Disease-Causing ?-Synuclein (Ala30Pro) Mutation -- Molecular Biology of Dopamine-Induced Apoptosis -- Animal Models of Induced Apoptotic Death in the Substantia Nigra -- Apoptotic Morphology in Phenotypically Defined Dopaminergic Neurons of the Substantia Nigra -- The Role of Nitric Oxide in Parkinson's Disease -- Oxidative Stress Indices in Parkinson's Disease -- Molecular Aspects of Basal Ganglia Function -- Quantification of Tyrosine Hydroxylase mRNA -- Immunochemical Analysis of Dopamine Transporters in Parkinson's Disease -- Dopamine Transporter and Vesicular Monoamine Transporter Knockout Mice -- Transcription Mechanisms for Dopamine Receptor Genes -- Detection of DNA/Protein Interactions in Dopamine Receptor Genes -- In Situ Hybridization on Brain Tissue -- Regulation of Striatal N-Methyl-D-Aspartate Receptor (NMDAR) Function by Phosphorylation of its Subunits in Parkinsonian Rats -- Molecular Therapies -- Chronic Intracerebral Delivery of Trophic Factors via a Programmable Pump as a Treatment for Parkinsonism -- Grafting Genetically Engineered Cells into the Striatum of Nonhuman Primates -- Encapsulated Cell Implants as a Novel Treatment for Parkinson's Disease -- Neural Stem Cell Technology as a Novel Treatment for Parkinson's Disease.
Keywords: Neurology .; Neurology